RPTX
Repare Therapeutics Inc
NASDAQ: RPTX · HEALTHCARE · BIOTECHNOLOGY
$2.65
+0.00% today
Updated 2026-01-28
Market cap
$114.24M
P/E ratio
—
P/S ratio
9.62x
EPS (TTM)
$-1.70
Dividend yield
—
52W range
$1 – $3
Volume
1.4M
Repare Therapeutics Inc (RPTX) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
6 of 8
Last 8 quarters
Avg EPS surprise
+37.8%
Last 4 quarters
Revenue YoY growth
-78.3%
Most recent quarter
EPS YoY growth
+109.9%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
+29.0%
Last 1 reports
Positive reaction rate
100%
1 of 1 quarters
Largest single-day move
+29.0%
2025-11-14
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2025-11-14 | $0.08 | +116.3% | $1.69 | $2.18 | +29.0% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-09-30 | $-0.49 | $0.08 | +116.3% | $11.62M | -78.3% |
| 2025-06-30 | $-0.56 | $-0.39 | +30.4% | $250000.00 | -76.7% |
| 2025-03-31 | $-0.63 | $-0.71 | -12.7% | — | — |
| 2024-12-31 | $-0.81 | $-0.67 | +17.3% | $-53.48M | -509.9% |
| 2024-09-30 | $-0.87 | $-0.81 | +6.9% | $53.48M | +2376.9% |
| 2024-06-30 | $-0.87 | $-0.82 | +5.7% | $1.07M | -96.5% |
| 2024-03-31 | $-0.78 | $0.30 | +138.3% | $52.40M | +822.9% |
| 2023-12-31 | $-0.36 | $-0.67 | -86.1% | $13.05M | -28.3% |
| 2023-09-30 | $-0.86 | $-0.45 | +47.7% | $2.16M | — |
| 2023-06-30 | $-0.78 | $-0.28 | +64.1% | $30.25M | — |
| 2023-03-31 | $-0.81 | $-0.83 | -2.5% | $5.68M | — |
| 2022-12-31 | $-0.72 | $-0.75 | -4.2% | $18.20M | — |
Frequently asked questions
Has Repare Therapeutics Inc beaten earnings estimates?
Repare Therapeutics Inc has beaten Wall Street EPS estimates in 6 of its last 8 quarterly reports, with an average EPS surprise of +37.8% over the last 4 quarters.
How does RPTX stock react to earnings?
RPTX stock has moved an average of +29.0% in the trading day following earnings over its last 1 reports, with positive reactions in 100% of those quarters.
What is Repare Therapeutics Inc's revenue growth rate?
Repare Therapeutics Inc reported year-over-year revenue growth of -78.3% in its most recent quarter, with EPS growing +109.9% year-over-year.